Skip to content

Diagnosis of Primary Ciliary Dyskinesia

Molecular Diagnosis of Primary Ciliary Dyskinesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00783887
Acronym
DCP
Enrollment
125
Registered
2008-11-03
Start date
2010-01-31
Completion date
2012-12-31
Last updated
2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kartagener Syndrome, Primary Ciliary Dyskinesia

Keywords

Cilia, Axoneme, Dynein, Gene, Ultrastructure, Linkage analysis

Brief summary

Primary ciliary dyskinesia is an inherited respiratory disease caused by various functional and ultrastructural abnormalities of respiratory cilia. The genetic heterogeneity underlying PCD is extremely important and only few genes are clearly implicated in PCD. Their mutations account for about 20% of patients. For all the other PCD patients, the genes responsible for their ciliary defect remain to be identify.

Detailed description

1/ Evaluating the frequency of mutations of the two main genes implicated in PCD, in a large cohort of patients with PCD confirmed by ciliary investigations.2/ Identifying and testing new candidate genes responsible not only for typical PCD and related disorders of the axoneme, but also for so far-unexplored syndromic forms of PCD, taking advantage of data obtained through comparative genomic approaches between different species, ciliated or not.

Interventions

OTHERBlood sample

Blood sample of 5 ml

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with suspected or confirmed primary ciliary dyskinesia after ciliary investigations who accepted to participate to the genetic studies.

Exclusion criteria

* Patients with exclusion of primary ciliary dyskinesia after ciliary investigations.

Design outcomes

Primary

MeasureTime frame
After DNA extraction,standard procedures for the identification of human gene mutations will be used for each gene tested in the studyAt the inclusion visit

Secondary

MeasureTime frame
Complementary ciliary investigations in patients with suspected primary ciliary dyskinesia.At the inclusion visit

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026